The CEO's personal purchase following a strong earnings beat and raised guidance is a modestly bullish signal. While the dollar amount is small, it reinforces management's confidence in the raised 2026 outlook. Monitor for any insider sales in the coming weeks; if no selling materializes, the signal strengthens. The stock is up ~18% since the earnings release, the buy at $20 suggests management sees further upside.
ELAN drugs
ELAN drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 20 $20.83entry
- T+1 · 6mo ago +2.26%α +2.06% · $21.30
- T+5 · 6mo ago +15.03%α +13.23% · $23.96
- T+20 · 5mo ago +12.30%α +12.34% · $23.39
- T+60 · 3mo ago +13.64%α +8.90% · $23.67
Price Chart
How similar events traded
Executive Summary
CEO Jeffrey Simmons and executive Rajeev Modi made open-market purchases totaling ~$200K on May 15, 2026, just 9 days after Elanco reported a strong Q1 2026 beat (EPS $0.40 vs $0.34 consensus, revenue +15% YoY) and raised full-year guidance. The purchases are small relative to the $10B market cap (~0.002%), but the CEO's personal cash outlay and the proximity to a bullish earnings catalyst amplify the signal. The cluster is a modestly bullish signal, consistent with management's confidence in the raised outlook.
Key Financial Metrics
Key Facts
- CEO Jeffrey Simmons purchased 4,971 shares at $20.09 for ~$100K on May 15, 2026.
- Executive Rajeev Modi purchased 4,911 shares at $20.35 for ~$100K on May 15, 2026.
- Total open-market purchases: ~$200K, representing ~0.002% of $10B market cap.
- Purchases occurred 9 days after Q1 2026 earnings beat (EPS $0.40 vs $0.34 consensus, revenue $1.371B vs $1.28B consensus) and raised full-year guidance.
- No open-market sales in the cluster; all other transactions are non-cash grants/awards.
Financial Impact
~$200K in open-market purchases by CEO and executive, immaterial relative to $10B market cap
Risk Factors
- Purchase size is trivial relative to market cap, may be symbolic rather than conviction-driven.
- The stock has already rallied ~18% post-earnings, potentially pricing in the good news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELAN-1779223191563 |
Track record
19 reports on ELAN
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +13.74% at T+5 after the May 19, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $26.78 Now $26.41 −1.38% settles Feb 11
- Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
- Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
- Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
- Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers